Please login to the form below
acne
This page shows the latest acne news and features for those working in and with pharma, biotech and healthcare.
Sanofi to buy acne specialist Origimm
Its first therapeutic vaccine candidate, ORI-001, based on recombinant proteins, entered preliminary clinical studies for acne vulgaris earlier this year. ... The Cutibacterium acnes bacterium plays a central role in the development of moderate to severe
Latest news
-
Galderma unites rosacea sufferers from around the globe in an empowering social media awareness movement: #RosaceaUnmasked
mask-wearing on skin health, including for acne and rosacea sufferers.
-
Bayer extends alliance with Evotec in women’s health
It’s caused by the production of higher than usual levels of male hormones and aside from fertility issues can also lead to obesity, hair loss and acne, as well as
-
Realm toppled by second mid-stage trial flop
We are conducting a full review to determine whether there is a path forward for our proprietary technology in atopic dermatitis, and to evaluate the implications for our acne and psoriasis ... programmes.”. Both of those are still in preclinical
-
Almirall acquires Allergan’s dermatology portfolio for $650m
years. This particular treatment is aimed to treat moderate-to-severe acne vulgaris in patients aged nine years and older and is scheduled for FDA evaluation later this year. ... Almirall will also adopt a further four already-marketed products,
-
Novartis pushes ‘virtual’ clinical trial concept
It’s already running semi-virtual trials for non-alcoholic steatohepatitis (NASH), acne and cluster headache.
More from news
Approximately 4 fully matching, plus 73 partially matching documents found.
Latest Intelligence
-
Embracing digital disruption in pharma
HelloSkin is the number one online store for emollients, nutrition supplements, accessories and selected over-the-counter products for people living with psoriasis, eczema, acne and dry skin.
-
Communicating health messages
For instance: 'Say hello to clear skin and goodbye to acne without any irritation.'.
-
Deal Watch November 2015
The deal includes Protopic (tacrolimus) for severe eczema treatment, skin creams Locoid and Locobase and acne therapy Zineryt (erythromycin/zinc acetate).
-
Pharma deals during November 2012
acne vulgaris. ... 255. DUSA / Sun Pharma. Acquisition. Levulan to treat non-hyperkeratotic actinic keratosis; BLU-U, to treat acne vulgaris.
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
New starters join Four Communications, Emotive and McCann Health
We’re delighted to have her join our team.”. Taylor is no stranger to the agency sector; prior to joining McCann Health, Taylor served as Global Client Lead for Galderma ACNE
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
DJM PAN Unlimited triumphs at IPA Best of Health Awards
The agency was also presented with two Bronze awards: for Exhausted’ for Comfort (Cow&Gate) in the same category; and the acne campaign Behind the Façade’ for Stiefel in the Health
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Sanofi's frexalimab shows promise in relapsing forms of MS
- Amgen reports positive results for Otezla in psoriatic arthritis
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Seqera Labs and Genomics England partner to progress genomic research
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s RSV vaccine approved by FDA for older adults
No results were found
PMHub
fox&cat
Fox&cat is a new kind of fully-integrated communications agency – one that delivers genuinely inspirational campaigns and programmes with equal...
Latest intelligence
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
